June 25, 2020
, a Switzerland-based pharmaceutical company, along with its Greek subsidiary, Novartis Hellas S.A.C.I.
(Novartis Greece), have agreed to pay $233 million to the DOJ and $112 to the SEC, for a combined penalty of $345 million
, in order to resolve charges of violating the Foreign Corrupt Practices Act. A former subsidiary, Alcon Pte Ltd
—now a subsidiary of multinational eyecare company, Alcon Ltd—has agreed to pay $8.9 million
to resolve similar charges. Between 2012 and 2016, the subsidiaries allegedly bribed employees of state-owned hospitals and clinics in Greece and Vietnam to use Novartis or Alcon-branded products while falsely recording the improper payments. As part of the settlement, both Novartis Greece and Alcon Pte Ltd will also enter into deferred prosecution agreements with DOJ. DOJ
; USAO NJ